• Citer

Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study

par Luen, Stephen;Michiels, Stefan ;Loi, Sherene ;Salgado, Roberto;Fox, Stephen B;Savas, Peter;Eng-Wong, Jennifer;Clark, Emma;Kiermaier, Astrid;Swain, Sandra S.M.;Baselga, José
Référence Lancet oncology, 18, 1, page (52-62)
Publication Publié, 2017-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study
Auteur:	Luen, Stephen; Michiels, Stefan; Loi, Sherene; Salgado, Roberto; Fox, Stephen B; Savas, Peter; Eng-Wong, Jennifer; Clark, Emma; Kiermaier, Astrid; Swain, Sandra S.M.; Baselga, José
Informations sur la publication:	Lancet oncology, 18, 1, page (52-62)
Statut de publication:	Publié, 2017-01
Sujet CREF:	Cancérologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1470-2045
	info:doi/10.1016/S1470-2045(16)30631-3
	info:pii/S1470204516306313
	info:scp/85007484031